TrialBreast cancer research and treatment2022

An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer.

Elgene Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.